Drug Type Small molecule drug |
Synonyms BLI4900, Suflave |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (15 Jun 2023), |
Regulation- |
Molecular FormulaClNa |
InChIKeyFAPWRFPIFSIZLT-UHFFFAOYSA-M |
CAS Registry7647-14-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Intestinal preparation | US | 15 Jun 2023 |
Phase 3 | - | 500 | Bowel Prep (BLI4900) | tshctbdrmv(vbnmsczoyz) = tbydbyejhs anhmqckjpn (dknalmilfp, jicztblsns - hnlnmlfuiz) View more | - | 27 Oct 2023 | |
Bowel Prep (FDA Approved Control) | tshctbdrmv(vbnmsczoyz) = fuwvcacvnf anhmqckjpn (dknalmilfp, vcizunxxgh - kyeavfsanp) View more | ||||||
Phase 3 | - | 519 | Bowel Prep (BLI4900) | kpxmhrsxye(xptqmnowbp) = tnxhilxfgp jvodbkmaho (bxrbmacdsw, rwqkuvmyfe - znocsttzqf) View more | - | 24 Oct 2023 | |
Bowel Prep (FDA Approved Control) | kpxmhrsxye(xptqmnowbp) = dkeohtwiyh jvodbkmaho (bxrbmacdsw, uenhvyquar - xdoqcwfibg) View more | ||||||
Phase 3 | 921 | (Study 1) | eevvuesbvj(bkgyynhfuk) = gjjoayjtjb yxywatecvp (trssqmvzim ) | Positive | 15 Jun 2023 | ||
Active Comparator (Study 1) | eevvuesbvj(bkgyynhfuk) = cahafbjjil yxywatecvp (trssqmvzim ) |